These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
474 related articles for article (PubMed ID: 7712437)
1. Increased risk of second malignant neoplasms outside radiation fields in patients with cervical carcinoma. Werner-Wasik M; Schmid CH; Bornstein LE; Madoc-Jones H Cancer; 1995 May; 75(9):2281-5. PubMed ID: 7712437 [TBL] [Abstract][Full Text] [Related]
2. Incidences and risk factors of metachronous vulvar, vaginal, and anal cancers after cervical cancer diagnosis. Matsuo K; Blake EA; Machida H; Mandelbaum RS; Roman LD; Wright JD Gynecol Oncol; 2018 Sep; 150(3):501-508. PubMed ID: 30054103 [TBL] [Abstract][Full Text] [Related]
3. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. Chaturvedi AK; Engels EA; Gilbert ES; Chen BE; Storm H; Lynch CF; Hall P; Langmark F; Pukkala E; Kaijser M; Andersson M; Fosså SD; Joensuu H; Boice JD; Kleinerman RA; Travis LB J Natl Cancer Inst; 2007 Nov; 99(21):1634-43. PubMed ID: 17971527 [TBL] [Abstract][Full Text] [Related]
4. Italian cancer figures, report 2013: Multiple tumours. AIRTUM Working Group Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384 [TBL] [Abstract][Full Text] [Related]
5. Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk? Wu GX; Nelson RA; Kim JY; Raz DJ Clin Lung Cancer; 2017 Sep; 18(5):543-550.e3. PubMed ID: 28412093 [TBL] [Abstract][Full Text] [Related]
6. Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer. Galper S; Gelman R; Recht A; Silver B; Kohli A; Wong JS; Van Buren T; Baldini EH; Harris JR Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):406-14. PubMed ID: 11872286 [TBL] [Abstract][Full Text] [Related]
7. Subsequent malignancies associated with carcinoma of the uterine cervix: including an analysis of the effect of patient and treatment parameters on incidence and sites of metachronous malignancies. Kapp DS; Fischer D; Grady KJ; Schwartz PE Int J Radiat Oncol Biol Phys; 1982 Feb; 8(2):197-205. PubMed ID: 7085375 [TBL] [Abstract][Full Text] [Related]
8. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study. Hisada M; Chen BE; Jaffe ES; Travis LB J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716 [TBL] [Abstract][Full Text] [Related]
9. Second primary anal and oropharyngeal cancers in cervical cancer survivors. Papatla K; Halpern MT; Hernandez E; Brown J; Benrubi D; Houck K; Chu C; Rubin S Am J Obstet Gynecol; 2019 Nov; 221(5):478.e1-478.e6. PubMed ID: 31128108 [TBL] [Abstract][Full Text] [Related]
10. Risk of metachronous ovarian cancer after ovarian conservation in young women with stage I cervical cancer. Matsuo K; Machida H; Horowitz MP; Shahzad MMK; Guntupalli SR; Roman LD; Wright JD Am J Obstet Gynecol; 2017 Nov; 217(5):580.e1-580.e10. PubMed ID: 28666700 [TBL] [Abstract][Full Text] [Related]
11. Malignancies diagnosed before and after anal squamous cell carcinomas: A SEER registry analysis. Jani KS; Lu SE; Murphy JD; Romesser PB; Jethwa KR; Li D; Chundury A; Wu AJ; Hathout L; Hallemeier CL; Jabbour SK Cancer Med; 2021 Jun; 10(11):3575-3583. PubMed ID: 33960690 [TBL] [Abstract][Full Text] [Related]
12. Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study. Teng CJ; Hu YW; Chen SC; Yeh CM; Chiang HL; Chen TJ; Liu CJ J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26538627 [TBL] [Abstract][Full Text] [Related]
13. Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors. Balamurugan A; Ahmed F; Saraiya M; Kosary C; Schwenn M; Cokkinides V; Flowers L; Pollack LA Cancer; 2008 Nov; 113(10 Suppl):2919-25. PubMed ID: 18980275 [TBL] [Abstract][Full Text] [Related]
14. A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations. Brown AP; Neeley ES; Werner T; Soisson AP; Burt RW; Gaffney DK Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):127-35. PubMed ID: 19910129 [TBL] [Abstract][Full Text] [Related]
15. Increased risk of second primary malignancies in patients with gynecological cancer. A Swedish record-linkage study. Bergfeldt K; Einhorn S; Rosendahl I; Hall P Acta Oncol; 1995; 34(6):771-7. PubMed ID: 7576744 [TBL] [Abstract][Full Text] [Related]
16. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up. Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271 [TBL] [Abstract][Full Text] [Related]
17. Incidence of invasive cancers following squamous cell skin cancer. Levi F; Randimbison L; La Vecchia C; Erler G; Te VC Am J Epidemiol; 1997 Nov; 146(9):734-9. PubMed ID: 9366621 [TBL] [Abstract][Full Text] [Related]
18. Treatment of squamous cell carcinoma of the uterine cervix with radiation therapy alone: long-term survival, late complications, and incidence of second cancers. Ota T; Takeshima N; Tabata T; Hasumi K; Takizawa K Br J Cancer; 2007 Oct; 97(8):1058-62. PubMed ID: 17895888 [TBL] [Abstract][Full Text] [Related]
19. Second Primary Malignancies in Mantle Cell Lymphoma: A US Population-based Study. Shah BK; Khanal A Anticancer Res; 2015 Jun; 35(6):3437-40. PubMed ID: 26026107 [TBL] [Abstract][Full Text] [Related]
20. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer. Brown AP; Chen J; Hitchcock YJ; Szabo A; Shrieve DC; Tward JD J Clin Endocrinol Metab; 2008 Feb; 93(2):504-15. PubMed ID: 18029468 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]